X
CRUK and Owlstone launch trial for cancer breath test
https://pharmaphorum.com/news/cruk-and-owlstone-launch-trial-for-cancer-breath-test/
Owlstone Medical
Owlstone adds AstraZeneca to roster of Breath Biopsy partners
Owlstone Medical, one of the UK’s most promising medtech start-ups, is continuing its expansion into pharma partnering via a new deal with AstraZeneca.
Breath Biopsy company adds new investor to $15m fundraising
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath has been given a major funding boost.
Major trial for potential ‘game changer’ cancer diagnostic begins
Breath Biopsy will be tested in its ability to detect several cancers earlier than traditional methods.
Digital health round-up: FDA digital unit on track
Employment has begun of digital health unit engineers.
Are you ready for your colonoscopy? Owlstone partners with Mayo Clinic on test
Tool will help distinguish between those prepared for a colonoscopy and those that aren’t.
Owlstone’s breath diagnostic to be used in asthma research
Owlstone’s ReCIVA and FAIMS technologies will be used to discover asthma-specific biomarkers.
1 2
